BIOMAT Database Logo BIOMAT Database Logo

Leu 193 mutation in the cysteine rich region of the insulin receptor inhibits the cleavage of the insulin receptor precursor but not insulin binding. 1994

Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
First Department of Medicine, Toyama Medical and Pharmaceutical University, Japan.

To characterize the Leu 193 mutant insulin receptor, which was found in a patient with extreme insulin resistance, the mutant insulin receptor was overexpressed in Rat-1 fibroblasts by transfection of mutated insulin receptor cDNA. In the pulse-chase experiment, the cleavage of the proreceptors to the matured receptor subunits was impaired in the cells expressing Leu 193 insulin receptor and therefore, the mutant proreceptors were accumulated in the cell. Insulin bound to the Leu 193 insulin receptor on the cell surface with normal affinity, although the mutation was in the alpha-subunit of the insulin receptor. Therefore, the Leu 193 mutation impaired proreceptor cleavage but not insulin binding.

UI MeSH Term Description Entries
D007163 Immunosorbent Techniques Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Immunoadsorbent Techniques,Immunoadsorbent Technics,Immunosorbent Technics,Immunoadsorbent Technic,Immunoadsorbent Technique,Immunosorbent Technic,Immunosorbent Technique,Technic, Immunoadsorbent,Technic, Immunosorbent,Technics, Immunoadsorbent,Technics, Immunosorbent,Technique, Immunoadsorbent,Technique, Immunosorbent,Techniques, Immunoadsorbent,Techniques, Immunosorbent
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D007930 Leucine An essential branched-chain amino acid important for hemoglobin formation. L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011498 Protein Precursors Precursors, Protein
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine

Related Publications

Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Localization of the insulin-binding site to the cysteine-rich region of the insulin receptor alpha-subunit.
November 1988, Biochemical and biophysical research communications,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding.
May 1994, The Journal of biological chemistry,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Mutation of the high cysteine region of the human insulin receptor alpha-subunit increases insulin receptor binding affinity and transmembrane signaling.
September 1989, The Journal of biological chemistry,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation.
October 2021, Cell reports,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region.
March 2000, FEBS letters,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
May 2002, Diabetologia,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Vanadate, but not insulin, inhibits insulin receptor gene expression in rat hepatoma cells.
November 1997, Endocrinology,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.
December 2004, The Journal of biological chemistry,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance.
September 1993, Human molecular genetics,
Y Takata, and T Imamura, and T Haruta, and K Egawa, and Y Takada, and T Sawa, and G H Yang, and M Kobayashi
Glycine-rich region of mitochondrial processing peptidase alpha-subunit is essential for binding and cleavage of the precursor proteins.
November 2000, The Journal of biological chemistry,
Copied contents to your clipboard!